cyanocobalamin 50microgram tablets
alissa healthcare research ltd - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin 50microgram tablets
sigma pharmaceuticals plc - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin 50microgram tablets
mawdsley-brooks & company ltd - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin 50microgram tablets
alliance healthcare (distribution) ltd - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin 50microgram tablets
advanz pharma - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin 50microgram tablets
dawa ltd - cyanocobalamin - oral tablet - 50microgram
cyanocobalamin injection
a-s medication solutions - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: addisonian (pernicious) anemia gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy fish tapeworm infestation malignancy of pancreas or bowel folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementatio
cyanocobalamin 50microgram tablets
p.i.e. pharma ltd - cyanocobalamin - oral tablet - 50microgram
cyanocobalamine- cyanocobalamine injection injection
henry schein, inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: •addisonian (pernicious) anemia •gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy •fish tapeworm infestation •malignancy of pancreas or bowel •folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementation. cyanocobalamin injection, usp is also suitable for the vitamin b12 absorption test (schilling test). sensitivity to cobalt and/or vitamin b12 is a contraindication.
x- cyanocobalamin powder
ax pharmaceutical corp - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 497.5 g in 500 g